search

Medica, one of the biggest medical technology trade fairs in the world, welcomes numerous international exhibitors and experts from the healthcare sector every year. Over 5,200 exhibitors will be present at this year’s edition, including several innovative Luxembourg companies that are advancing the frontiers of medical care.

By careful bio-engineering we create products that can be stored twice as long as the industry standard.

Poly Diagnostics, a recent graduate of the startup acceleration programme Fit 4 Start, will be part of the Luxembourg delegation at the Medica trade fair in Düsseldorf from 13 to 16 November. Myroslav Gebura, the company’s founder, is optimistic about the possibility for strategic alliances that will advance the company’s objective to improve healthcare through innovative IVD solutions. Luxembourg has a national pavilion in hall 3, stand A74.

What does your company offer in the field of health technologies?

Imagine you or your pet got sick and you would like to know what kind of pathogens caused the illness. Would you prefer to be tested for a single virus or bacteria at the time or for all the suspected causative agents at once?

Now suppose you are a doctor who has to perform the clinical test – would you like to spend 5 hours of time per test or you would like to finish it in less than 1 hour? Or maybe you would like to avoid buying specialised equipment for the storage of your reagents, or you would like your reagents to have a two-fold longer shelf life than the industry standard?

Being a part of Luxembourg’s vibrant and international community has been a source of inspiration. It’s a place where innovation thrives.

At Poly Diagnostics, we address exactly these issues and develop a portfolio of ready-to-use in-vitro diagnostic products in the dry format for the detection of multiple human pathogens at once.

By careful bio-engineering we create products that can be stored twice as long as the industry standard, have simple and user-friendly product handling, extraction-free IVD tests, less consumables (filter tips, mixing plates etc.), no storage equipment required, and products can be stored and transported at room temperature.

What is the objective of your participation at MEDICA?

Poly Diagnostics, as a Luxembourg-based startup specialising in instant format dry RT-PCR kits, aims to leverage its presence at Medica to solidify its position in the In Vitro Diagnostic (IVD) industry. By engaging with global healthcare professionals and experts, the company seeks to form strategic partnerships, gain industry insights, and boost its brand recognition, ultimately advancing its mission to enhance healthcare with innovative IVD solutions.

What has your experience been like as a startup in Luxembourg?

Our journey as a startup in Luxembourg has been nothing short of success. The pivotal moment in our trajectory was receiving the prestigious governmental support grant via the Fit 4 Start programme, which provided us with resources and guidance to continue our innovative endeavors.

The company seeks to form strategic partnerships, gain industry insights, and boost its brand recognition.

Luxinnovation, a dedicated governmental agency committed to nurturing startups, played a pivotal role in our growth too. Their unwavering support and mentorship have enabled us to refine our vision and strategies.

Being a part of Luxembourg’s vibrant and international community has been a source of inspiration. It’s a place where innovation thrives, and we are proud to contribute to this dynamic ecosystem. The collaborative spirit, the proximity to other forward-thinking companies, and the availability of facilities have all contributed to our success.

Photo credit: Poly Diagnostics

Read more

Luxembourg to build AI-optimised supercomputer

11-03-2025

The Ministers of Economy and Research presented the roadmap for the national supercomputer optimised for artificial intelligence and the associated AI Factory.
Read more

AciesNova’s 5G solution takes root in Luxembourg

11-03-2025

The company offers an alternative 5G solution for public and private networks and has incorporated in Luxembourg to benefit from its stable business environment.
Read more

Luxembourg startup speeds up drug discovery using AI models

18-02-2025

Helical has trained a state-of-the-art mRNA bio foundation model to accelerate mRNA therapy research, outperforming similar models from leading pharma companies.
Read more

Co-creating solutions for the future of composite technologies

11-02-2025

Kordsa's expertise in reinforcement materials aligns with SCMM's goal to develop composite materials with low carbon footprint. Both entities are exploring high-potential projects in the next three years.
Read more

How the European Health Data Space is catalysing innovation

06-02-2025

The European Digital Healthtech Conference 2025 will explore the transformative impact of the European Health Data Space (EHDS) on digital health solutions.
Read more

Resources all news

Fermer